HedgePath Pharmaceuticals, Inc.

Common Stock SEC Reporting - Current
Verified Company Profile 11/30/2016
Contact Info
  • 324 South Hyde Park Avenue
  • Suite 350
  • Tampa, FL 33606

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001042418
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 8731 - Commercial physical research
Business Status Development Stage Company a/o
Incorporated In: DE, USA
Year of Inc. 2013
Employees 4 a/o Nov 07, 2016
Company Officers/Contacts
Nicholas Virca CEO, President
Garrison J. Hasara CFO, Treasurer
James McNulty Secretary, Compliance Officer
Company Directors
Francis E O'Donnell Chairman
Stefan Cross
Dana Ono
Samuel P. Sears
W. Mark Watson
Company Notes
  • Formerly=Commonwealth Biotechnologies, Inc. until 8-2013
Service Providers
Accounting/Auditing Firm
Cherry Bekaert LLP
401 East Jackson St
Suite 3400
Tampa, FL, 33602
United States

Legal Counsel
Ellenoff Grossman & Schole LLP
1345 Avenue of the Americas
New York, NY, 10105
United States

Investor Relations Firm
Not Available
HPPI Security Details
Share Structure
Market Value1 $127,228,382 a/o Dec 02, 2016
Authorized Shares 500,000,000 a/o Nov 16, 2016
Outstanding Shares 353,412,172 a/o Nov 16, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 57,218,971 a/o Nov 09, 2016
Par Value No Par Value
Shareholders of Record 54 a/o Nov 07, 2016
Short Selling Data
Short Interest 5,269 (70.68%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security